Next Article in Journal
Enhancer Clusters Drive Type I Interferon-Induced TRAIL Overexpression in Cancer, and Its Intracellular Protein Accumulation Fails to Induce Apoptosis
Next Article in Special Issue
Implementation of Machine Learning Models to Ensure Radiotherapy Quality for Multicenter Clinical Trials: Report from a Phase III Lung Cancer Study
Previous Article in Journal
CDK4/6 Inhibitors in Pancreatobiliary Cancers: Opportunities and Challenges
Previous Article in Special Issue
Radiomics-Based Inter-Lesion Relation Network to Describe [18F]FMCH PET/CT Imaging Phenotypes in Prostate Cancer
 
 
Article
Peer-Review Record

Development of a Novel Intra-Operative Score to Record Diseases’ Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in Advanced-Stage Ovarian Cancer by Using Machine Learning and Explainable Artificial Intelligence

Cancers 2023, 15(3), 966; https://doi.org/10.3390/cancers15030966
by Alexandros Laios 1,*,†, Evangelos Kalampokis 2,†, Racheal Johnson 1, Sarika Munot 1, Amudha Thangavelu 1, Richard Hutson 1, Tim Broadhead 1, Georgios Theophilou 1, David Nugent 1 and Diederick De Jong 1
Reviewer 1: Anonymous
Reviewer 2:
Cancers 2023, 15(3), 966; https://doi.org/10.3390/cancers15030966
Submission received: 2 December 2022 / Revised: 30 January 2023 / Accepted: 31 January 2023 / Published: 3 February 2023
(This article belongs to the Collection Artificial Intelligence in Oncology)

Round 1

Reviewer 1 Report

I suggest the authors to provide several figures (such as CT scan, MRI or OP pictures) to illustrate the difference among ANAFI, PCI and IMO tools in EOC patients with complete resection and incomplete resection. It will help the readers easy to catch the points of the manuscript.

Author Response

The ANAFI score is an intraoperative score and the main aim of the study was to introduce the score using ML algorithms and XAI and test it against the PCI and IMO scores. We will be willing to explore the value of a radiological ANAFI score in our follow-on study. We argue the low performance of the PCI score. Herein we highlight the value of a novel intraoperative score based on the weighted importance of intraoperative features early assessed that outperform all composite features in the prediction of complete cytoreduction. A paragraph with references is dedicated in the Discussion section.

Reviewer 2 Report

Dear Authors,

 

thank you for submitting this manuscript. In the field of gyn onco we still lack optimal tool for patient selection - which is a key moment for successful therapy.

You research is meticulous, scientific sound and convincing. I find it suitable for publication.

 

Author Response

Many thanks for your positive feedback.

Back to TopTop